Skip to main content
Log in

Effect of Chronic Administration of Obestatin and Its Fragment FNAP-NH2 on Behavioral Activity and Nociceptive Threshold in Rats with Normal and Excess Body Weight

  • PHYSIOLOGY
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

The effects of chronic intranasal administration of 300 nmol/kg obestatin and its fragment FNAP-NH2 on behavioral activity and nociceptive threshold were examined in male Wistar rats with normal body weight or alimentary obesity. In normal rats, obestatin produced no effect on behavior and nociception, whereas FNAP-NH2 fragment enhanced risk-taking behavior. Rats with excess body weight demonstrated less pronounced risk-taking behavior and elevated nociceptive threshold in comparison with normal animals, but these differences were abolished by chronic administration of FNAP-NH2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Motorykina ES, Khirazova EE, Maslova MV, Maklakova AS, Graf AV, Bayzhymanov AA, Kurko OD, Zamyatina LA, Andreyeva LA, Sokolova NA, Myasoyedov NF, Kamenskii AA. Changes in feeding and drinking motivations and glucose content in male rats after single or chronic administration of obestatin or its fragment (1-4). Dokl. Biol. Sci. 2015;460:1-4.

    Article  CAS  PubMed  Google Scholar 

  2. Khirazova EE, Bayzhumanov AA, Motorykina ES, Devyatov AA, Maslova MV, Graf AV, Sokolova NA, Golubeva MG, Kamenskii AA. Antioxidant defense system after single and chronic administration of obestatin and its fragment (1-4) to normal and overweight male rats. Bull. Exp. Biol. Med. 2015;159(1):38-40.

    Article  CAS  PubMed  Google Scholar 

  3. Khirazova EE, Maslova MV, Motorykina ES, Frid DA, Graf AV, Maklakova AS, Sokolova NA, Kamenskii AA. Effects of single intranasal administration of obestatin fragments on the body weight and feeding and drinking behaviors. Dokl. Biol. Sci. 2013;453:336-337.

    Article  CAS  PubMed  Google Scholar 

  4. Ataka K, Inui A, Asakawa A, Kato I, Fujimiya M. Obestatin inhibits motor activity in the antrum and duodenum in the fed state of conscious rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2008;294(5):G1210-G1218.

    Article  CAS  PubMed  Google Scholar 

  5. Aydin S, Ozkan Y, Erman F, Gurates B, Kilic N, Colak R, Gundogan T, Catak Z, Bozkurt M, Akin O, Sen Y, Sahn I. Presence of obestatin in breast milk: relationship among obestatin, ghrelin, and leptin in lactating women. Nutrition. 2008;24(7-8):689-693.

    Article  CAS  PubMed  Google Scholar 

  6. Bang AS, Soule SG, Yandle TG, Richards AM, Pemberton CJ. Characterisation of proghrelin peptides in mammalian tissue and plasma. J. Endocrinol. 2007;192(2):313-323.

    Article  CAS  PubMed  Google Scholar 

  7. Chanoine JP, Wong AC, Barrios V. Obestatin, acylated and total ghrelin concentrations in the perinatal rat pancreas. Horm. Res. 2006;66(2):81-88.

    CAS  PubMed  Google Scholar 

  8. Guneli E, Gumustekin M, Ates M. Possible involvement of ghrelin on pain threshold in obesity. Med. Hypotheses. 2010;74(3):452-454.

    Article  CAS  PubMed  Google Scholar 

  9. Huda MS, Durham BH, Wong SP, Deepak D, Kerrigan D, McCulloch P, Ranganath L, Pinkney J, Wilding JP. Plasma obestatin levels are lower in obese and post-gastrectomy subjects, but do not change in response to a meal. Int. J. Obes. (Lond). 2008;32(1):129-135.

    Article  CAS  Google Scholar 

  10. Liptak N, Dochnal R, Csabafi K, Szakacs J, Szabo G. Obestatin prevents analgesic tolerance to morphine and reverses the effects of mild morphine withdrawal in mice. Regul. Pept. 2013;186:77-82.

    Article  CAS  PubMed  Google Scholar 

  11. Price RC, Asenjo JF, Christou NV, Backman SB, Schweinhardt P. The role of excess subcutaneous fat in pain and sensory sensitivity in obesity. Eur. J. Pain. 2013;17(9):1316-1326.

    Article  CAS  PubMed  Google Scholar 

  12. Rouwette T, Klemann K, Gaszner B, Scheffer GJ, Roubos EW, Scheenen WJ, Vissers K, Kozicz T. Differential responses of corticotropin-releasing factor and urocortin 1 to acute pain stress in the rat brain. Neuroscience. 2011;183:15-24.

    Article  CAS  PubMed  Google Scholar 

  13. Zamrazilova H, Hainer V, Sedlacková D, Papezova H, Kunesova M, Bellisle F, Hill M, Nedvídkova J. Plasma obestatin levels in normal weight, obese and anorectic women. Physiol. Res. 2008;57(Suppl 1):S49-S55.

    CAS  PubMed  Google Scholar 

  14. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelins’ effects on food intake. Science. 2005;310:996-999.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. E. Khirazova.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 163, No. 3, pp. 268-270, March, 2017

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khirazova, E.E., Motorykina, E.S., Maslova, M.V. et al. Effect of Chronic Administration of Obestatin and Its Fragment FNAP-NH2 on Behavioral Activity and Nociceptive Threshold in Rats with Normal and Excess Body Weight. Bull Exp Biol Med 163, 293–295 (2017). https://doi.org/10.1007/s10517-017-3787-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-017-3787-x

Key Words

Navigation